GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Jibeier Pharmaceutical Co Ltd (SHSE:688566) » Definitions » 1-Year Sharpe Ratio

Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) 1-Year Sharpe Ratio : -0.72 (As of Jan. 28, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Jiangsu Jibeier Pharmaceutical Co 1-Year Sharpe Ratio?

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2025-01-28), Jiangsu Jibeier Pharmaceutical Co's 1-Year Sharpe Ratio is -0.72.


Competitive Comparison of Jiangsu Jibeier Pharmaceutical Co's 1-Year Sharpe Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Jibeier Pharmaceutical Co's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Jibeier Pharmaceutical Co's 1-Year Sharpe Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Jibeier Pharmaceutical Co's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Jiangsu Jibeier Pharmaceutical Co's 1-Year Sharpe Ratio falls into.



Jiangsu Jibeier Pharmaceutical Co 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.


Jiangsu Jibeier Pharmaceutical Co  (SHSE:688566) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Jiangsu Jibeier Pharmaceutical Co 1-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of Jiangsu Jibeier Pharmaceutical Co's 1-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Jibeier Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
High-tech Industrial Development Zone, Jiangsu Province, Zhenjiang, CHN, 212000
Jiangsu Jibeier Pharmaceutical Co Ltd specializes in the research, development, production and sales of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products include tablets, hard capsules, eye drops, and gels, agents, creams and other dosage. Its products are used in various application fields such as Cardiovascular drugs, Blood system drugs, Immune system drugs, Ophthalmic drugs, Antipyretic and analgesic drugs, Respiratory medicine, and other.
Executives
Wu Ying senior management
Zhang Chun Director
Zhao Suo Fu senior management
Li Hai Dao Core technical personnel
Di Jian Zhong senior management
Qin Xu Feng Core technical personnel
Wu Xiu Gen Core technical personnel
Yu Xin Jun Directors, senior managers
Li Zhao Guang Core technical personnel
Geng Zhong Yi Directors, senior managers, core technical personnel
Hu Tao Director

Jiangsu Jibeier Pharmaceutical Co Headlines

No Headlines